Why the study?
Do matrix metalloproteinase-2 and osteopontin predict incident atrial fibrillation in a general population?
Do matrix metalloproteinase-2 and osteopontin predict incident atrial fibrillation in a general population?
Answers are grounded in this paper and cite their sources.
Matrix metalloproteinase-2 and osteopontin are novel independent risk markers for incident atrial fibrillation, adding predictive value beyond traditional risk factors and NT-proBNP.
In a general Swedish population, we confirmed the well-known association of NT-proBNP with incident AF and also identified matrix metalloproteinase-2 and osteopontin as novel risk markers for incident AF, independently of traditional risk factors and NT-proBNP.
No takes yet. Share an insight, caveat, or question.
Molvin et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: